Hemenway Trust Hemenway Trust’s AbbVie ABBV Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.97M	Buy	22,851 +59	+0.3%	+$13.1K	0.4%	41
2025 Q4	$5.21M	Buy	22,792 +73	+0.3%	+$16.6K	0.4%	40
2025 Q3	$5.26M	Sell	22,719 -634	-3%	-$129K	0.4%	41
2025 Q2	$4.33M	Sell	23,353 -3,768	-14%	-$700K	0.34%	43
2025 Q1	$5.68M	Sell	27,121 -1,003	-4%	-$195K	0.46%	38
2024 Q4	$5M	Sell	28,124 -346	-1%	-$63.6K	0.41%	40
2024 Q3	$5.62M	Sell	28,470 -1,198	-4%	-$224K	0.44%	39
2024 Q2	$5.09M	Sell	29,668 -2,180	-7%	-$361K	0.44%	37
2024 Q1	$5.8M	Buy	31,848 +3,472	+12%	+$598K	0.5%	38
2023 Q4	$4.4M	Sell	28,376 -857	-3%	-$125K	0.42%	37
2023 Q3	$4.36M	Sell	29,233 -2,273	-7%	-$334K	0.46%	37
2023 Q2	$4.24M	Sell	31,506 -117	-0.4%	-$17.2K	0.42%	40
2023 Q1	$5.04M	Sell	31,623 -1,872	-6%	-$286K	0.53%	37
2022 Q4	$5.41M	Buy	33,495 +1,111	+3%	+$170K	0.6%	38
2022 Q3	$4.35M	Sell	32,384 -728	-2%	-$104K	0.51%	42
2022 Q2	$5.07M	Sell	33,112 -3,830	-10%	-$585K	0.58%	41
2022 Q1	$5.99M	Sell	36,942 -403	-1%	-$58.5K	0.58%	42
2021 Q4	$5.06M	Sell	37,345 -1,338	-3%	-$158K	0.46%	43
2021 Q3	$4.17M	Sell	38,683 -89	-0.2%	-$10.2K	0.42%	42
2021 Q2	$4.37M	Sell	38,772 -697	-2%	-$78.5K	0.44%	42
2021 Q1	$4.27M	Sell	39,469 -764	-2%	-$81.7K	0.47%	43
2020 Q4	$4.31M	Buy	40,233 +868	+2%	+$83.4K	0.49%	44
2020 Q3	$3.45M	Buy	39,365 +1,236	+3%	+$116K	0.45%	43
2020 Q2	$3.74M	Sell	38,129 -190	-0.5%	-$16.7K	0.52%	42
2020 Q1	$2.92M	Buy	38,319 +2,980	+8%	+$254K	0.49%	41
2019 Q4	$3.13M	Buy	35,339 +256	+0.7%	+$21.3K	0.45%	41
2019 Q3	$2.66M	Sell	35,083 -2,282	-6%	-$156K	0.42%	43
2019 Q2	$2.72M	Sell	37,365 -806	-2%	-$63.4K	0.42%	44
2019 Q1	$3.08M	Buy	38,171 +3,999	+12%	+$327K	0.5%	41
2018 Q4	$3.15M	Sell	34,172 -91	-0.3%	-$8K	0.64%	40
2018 Q3	$3.24M	Buy	34,263 +1,311	+4%	+$124K	0.55%	42
2018 Q2	$3.05M	Buy	32,952 +1,586	+5%	+$155K	0.56%	42
2018 Q1	$2.97M	Buy	31,366 +730	+2%	+$80.2K	0.56%	42
2017 Q4	$2.96M	Sell	30,636 -894	-3%	-$84.3K	0.56%	42
2017 Q3	$2.8M	Sell	31,530 -307	-1%	-$23.4K	0.59%	42
2017 Q2	$2.31M	Buy	31,837 +560	+2%	+$37.6K	0.51%	46
2017 Q1	$2.04M	Buy	31,277 +773	+3%	+$48.6K	0.47%	46
2016 Q4	$1.91M	Sell	30,504 -211	-0.7%	-$12.9K	0.48%	50
2016 Q3	$1.94M	Buy	30,715 +704	+2%	+$45.6K	0.48%	50
2016 Q2	$1.86M	Sell	30,011 -84	-0.3%	-$5.12K	0.48%	49
2016 Q1	$1.72M	Sell	30,095 -655	-2%	-$36.5K	0.46%	49
2015 Q4	$1.82M	Sell	30,750 -1,930	-6%	-$111K	0.48%	51
2015 Q3	$1.78M	Buy	32,680 +910	+3%	+$59.2K	0.49%	50
2015 Q2	$2.13M	Sell	31,770 -550	-2%	-$35.9K	0.55%	49
2015 Q1	$1.89M	Buy	32,320 +12,395	+62%	+$749K	0.5%	54
2014 Q4	$1.3M	Buy	19,925 +915	+5%	+$57.7K	0.39%	55
2014 Q3	$1.1M	Buy	19,010 +150	+0.8%	+$8.33K	0.34%	57
2014 Q2	$1.06M	Buy	18,860 +800	+4%	+$42K	0.32%	58
2014 Q1	$928K	Sell	18,060 -50	-0.3%	-$2.53K	0.29%	60
2013 Q4	$956K	Buy	18,110 +7,962	+78%	+$391K	0.31%	61
2013 Q3	$454K	Buy	10,148 +2,500	+33%	+$111K	0.17%	72
2013 Q2	$316K	Buy	+7,648	New	+$334K	0.13%	80

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hemenway Trust Hemenway Trust's ABBV Position: Q1 2026 in Review

Hemenway Trust Hemenway Trust increased its AbbVie (ABBV) stake by 0.26% in Q1 2026, buying an estimated $13.1K and bringing the position to 22,851 shares worth $4.97M. The position accounts for 0.4% of the portfolio, ranked #41.

Hemenway Trust Hemenway Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.99M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Hemenway Trust Hemenway Trust held 22,851 shares of AbbVie worth $4.97M as of Q1 2026.
Hemenway Trust Hemenway Trust bought 59 AbbVie shares in Q1 2026, an estimated $13.1K.
AbbVie made up 0.4% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #41 holding.
Hemenway Trust Hemenway Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Hemenway Trust Hemenway Trust's AbbVie position peaked at $5.99M in Q1 2022.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.